It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2004.
2004 | Mumbai, Maharashtra, India | Under LiquidationProteus Pharmaceuticals Private Limited, a under liquidation private limited company, was established on 27 April 2004 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2004PTC145936. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹4.00 M.
Its leadership includes Ramesh Purshottamdas Mehta (Director), Alpesh Shashikant Mehta (Director). It holds ₹153.80 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2008, with the balance sheet filed on 31 March 2008. It is based at 705 Godavari Svp Nagarmhada Layout Andheri (W), Mumbai, Maharashtra, 400053.
U24230MH2004PTC145936
145936
27 April 2004
₹2.00 Cr
₹4.00 M
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Proteus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Purshottamdas Mehta | Director | 03 Jan 2006 | Current |
| Alpesh Shashikant Mehta | Director | 10 Oct 2005 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Proteus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Proteus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,538,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2010 | Edelweiss Asset Reconstruction Company Limited | ₹48.25 Cr | Open |
| 18 Jun 2009 | Global Trade Finance Limited | ₹10.00 Cr | Open |
| 17 Mar 2009 | The Lakshmivilas Bank Limited | ₹25.00 Cr | Open |
| 23 Dec 2008 | The Lakshmivilas Bank Limited | ₹5.00 Cr | Open |
| 18 Oct 2008 | Edelweiss Asset Reconstruction Company Limited | ₹48.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Proteus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Proteus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proteus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 48.25 Cr registered on 23 Jan 2010 with Charge ID 10203915 was modified on 11 Feb 2011. was completed.
The activity A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 48.25 Cr registered on 18 Oct 2008 with Charge ID 10128591 was modified on 11 Feb 2011. was completed.
The activity A charge with Edelweiss Asset Reconstruction Company Limited amounted to Rs. 48.25 Cr with Charge ID 10203915 was registered on 23 Jan 2010. was completed.
The activity A charge with Global Trade Finance Limited amounted to Rs. 10.00 Cr with Charge ID 10161394 was registered on 18 Jun 2009. was completed.
The activity A charge with The Lakshmivilas Bank Limited of Rs. 25.00 Cr registered on 17 Mar 2009 with Charge ID 10154742 was modified on 11 May 2009. was completed.
A charge with The Lakshmivilas Bank Limited of Rs. 5.00 Cr registered on 23 Dec 2008 with Charge ID 10141476 was modified on 11 May 2009. was recorded as a recent event.
The CIN of Proteus Pharmaceuticals Private Limited is U24230MH2004PTC145936.
Proteus Pharmaceuticals Private Limited is headquartered at 705 Godavari Svp Nagarmhada Layout Andheri (W), Mumbai, Maharashtra, 400053.
Proteus Pharmaceuticals Private Limited was incorporated on 27 April 2004.
The current directors of Proteus Pharmaceuticals Private Limited are
The primary industry of Proteus Pharmaceuticals Private Limited is Pharma.
Proteus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Proteus Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹4.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX